Sandoz launches generic lenalidomide in 19 countries across Europe, expanding access to essential oncology medicine
- Lenalidomide Sandoz is indicated for use in several critical haematology-oncology conditions, per latest ESMO guidelines1,4
- Cost savings from Lenalidomide Sandoz can expand treatment options for patients with haemato-oncology conditions1,2
- Sandoz is committed to developing and providing generic oncology therapies, to provide patients access to affordable, high-quality …